BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic reviewJournal of Gastroenterology 2020; 55(5): 496 doi: 10.1007/s00535-020-01680-0
2
Rob Bielen, Geert Robaeys, Sigrid Schelfhout, Diethard Monbaliu, Schalk Van der Merwe, Jacques Pirenne, Frederik Nevens. Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort studyTransplant International 2018; 31(5): 503 doi: 10.1111/tri.13112
3
Jirayu Kammarabutr, Panupong Mahalapbutr, Hisashi Okumura, Peter Wolschann, Thanyada Rungrotmongkol. Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptaseJournal of Biomolecular Structure and Dynamics 2020; : 1 doi: 10.1080/07391102.2020.1751715
4
Bijayata Patra, Poulomi Ghosh, Saprativ P. Das. Model Organisms to Study Biological Activities and Toxicity of Nanoparticles2020; : 195 doi: 10.1007/978-981-15-1702-0_10
5
William W. L. Wong, Petros Pechivanoglou, Josephine Wong, Joanna M. Bielecki, Alex Haines, Aysegul Erman, Yasmin Saeed, Arcturus Phoon, Mina Tadrous, Mona Younis, Noha Z. Rayad, Valeria Rac, Harry L. A. Janssen, Murray D. Krahn. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trialsSystematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1126-1
6
Di Liu, Lin Liu, Lizheng Wang, Sizhu Duan, Yanan Song, Meng Qu, Nan Gao, Jiaxin Wu, Haihong Zhang, Hui Wu, Wei Kong, Bin Yu, Xianghui Yu. Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infectionMolecular Medicine Reports 2017;  doi: 10.3892/mmr.2017.8096
7
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu. Reactivation of Hepatitis B Virus in Patients with Multiple MyelomaCancers 2019; 11(11): 1819 doi: 10.3390/cancers11111819
8
Takayuki Fujii, Kei‐ichiro Takase, Hiroyuki Honda, Nobutoshi Kawamura, Ryo Yamasaki, Michiyo Urata, Takeshi Uchiumi, Toru Iwaki, Jun‐ichi Kira. Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case studyNeuropathology 2019; 39(2): 162 doi: 10.1111/neup.12548
9
Su-Shen Lim, Hsien-Tzung Liao, Chang-Youh Tsai. Telbivudine associated mitochondrial myopathyLiver International 2018; 38(6): 1139 doi: 10.1111/liv.13742
10
Soon Sun Kim, Eun Kyoung Ahn, Soo Yeon Cho, Rae Woong Park, Hyo Jung Cho, Ji-Hyun Kim, Han Gyeol Kim, Ga Ram Lee, Sun Hyuk Hwang, Min Jae Yang, Jae Youn Cheong, Sung Won Cho. Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis BMedicine 2018; 97(24): e11087 doi: 10.1097/MD.0000000000011087
11
Nese Inan, Fehmi Tabak. Viral Hepatitis: Chronic Hepatitis B2018; : 71 doi: 10.1007/978-3-319-93449-5_7
12
Kerui Xu, Li-Ming Liu, Paraskevi A. Farazi, Hongmei Wang, Fedja A Rochling, Shinobu Watanabe-Galloway, Jian-Jun Zhang. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis BGlobal Health Action 2018; 11(1): 1433987 doi: 10.1080/16549716.2018.1433987
13
H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patientsAlimentary Pharmacology & Therapeutics 2018; 47(12): 1673 doi: 10.1111/apt.14682
14
Sreekumar Othumpangat, John D. Noti. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2018; 40: 345 doi: 10.1016/bs.seda.2018.08.005
15
Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Ourania Kyriakopoulou, Dimitrios Velissaris. Neuropsychiatric Effects of Antiviral DrugsCureus 2020;  doi: 10.7759/cureus.9536
16
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration RateGut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
17
Idanna Innocenti, Francesca Morelli, Francesco Autore, Andrea Corbingi, Raffaella Pasquale, Federica Sorà, Maurizio Pompili, Luca Laurenti. HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxisLeukemia & Lymphoma 2019; 60(5): 1340 doi: 10.1080/10428194.2018.1523401
18
Suman Pilli, Peck Lin Lip. Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infectionEye 2018; 32(11): 1792 doi: 10.1038/s41433-018-0156-6
19
Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysisHepatobiliary & Pancreatic Diseases International 2020;  doi: 10.1016/j.hbpd.2020.09.007
20
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
21
Vitus Sambo Badii, Kwame Ohene Buabeng, Thomas Agyarko Poku, Arnold Donkor Forkuo, Bright Boafo Boamah, Stephen Mensah Arhin, Daniel Edem Kpewou. Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected AdultsInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/3702740